The themes Alcon is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Graded A or B and worth $2B or more: A first, then the largest.
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
売上構成比はFY2025の推計であり、提出された報告書の数字ではありません。
UNITY VCS and UNITY CS
Equipment systems used for retinal and cataract surgery. They help surgeons remove eye tissue or a cloudy natural lens and replace it.
PanOptix Pro
An artificial lens implanted during cataract surgery, designed to help patients see at near, middle and far distances.
Hydrus Microstent
A small device implanted during cataract surgery to help fluid drain from the eye and lower pressure in some people with glaucoma.
DAILIES TOTAL1
A daily disposable contact lens designed with a high-water-content surface for comfort.
Systane
Eye drops that temporarily relieve burning and irritation associated with dry eye.
TRYPTYR
Prescription eye drops for dry eye disease that stimulate natural tear production.
Alcon makes equipment and disposable supplies used in cataract, retinal, laser-vision and glaucoma surgery, as well as artificial lenses implanted during cataract operations. It also sells daily and reusable contact lenses and eye drops for dry eye, allergies, glaucoma and contact-lens care. Hospitals and surgery centers buy surgical products, while eye-care practices, retailers, pharmacies and distributors sell or prescribe its vision-care products.
Alcon Inc. 自身が米国証券取引委員会(SEC)に提出した書類にもとづきます。数字は報告されたままで、1 株当たりの履歴は今日の株数基準に修正済みです。 これは事業の説明です——投資助言ではなく、売買を勧めるものでもありません。
$74.13+3.2%11月13日 終値
2026年9月30日までの数値(2026年11月10日提出の6-Kより)
Alcon sells eye-surgery equipment and implants to hospitals and surgeons, and contact lenses and eye medicines to consumers through eye-care professionals and retailers.
Grade A
株価の下の帯は各日付時点の評価で、その時点までに公開された書類だけで算出しています。
Alcon Inc. の評価履歴 26 四半期のうち 2 四半期を表示しています。 残る 24 四半期は 2020年2月 まで遡ります。